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A B S T R A C T
A viable cell count is essential to evaluate the kinetics of cell growth. Since the hemocytometer was ﬁrst
used for counting blood cells, several variants of the methodology have been developed towards reducing
the time of analysis and improving accuracy through automation of both sample preparation and
counting. The successful implementation of automated techniques relies in the adjustment of cell
staining, image display parameters and cell morphology to obtain equivalent precision, accuracy and
linearity with respect to the hemocytometer. In this study we conducted the validation of three trypan
blue exclusion-based methods: manual, semi-automated, and fully automated; which were used for the
estimation of density and viability of cells employed for the biosynthesis and bioassays of recombinant
proteins. Our results showed that the evaluated attributes remained within the same range for the
automated methods with respect to the manual, providing an efﬁcient alternative for analyzing a huge
number of samples.
ã 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
A viable cell count is crucial for the study of eukaryotic cells for
different purposes such as the management of cell cultures in
biological research, the titration of cell populations in diagnostics,
and in-process controls in industrial bioprocesses [7,13,5].
Among the well-known viable cell count methods developed so
far, manual counting with a hemocytometer has been the most
commonly used method due to its low cost and versatility [4]. This
method depends on the analyst’s ability to evaluate different cell
attributes regardless of the cell type; in addition allows using
different staining techniques according to the purpose of the
analyses (Table 1). However, the procedure is time consuming,
which precludes the analysis of a large amount of samples at one
time and is subject to inter-user variation depending on the degree
of expertise of the analyst [6,8].
Currently, the arising of automated cell counting instruments
has provided the possibility of analyzing a huge number of samples
in a shorter time [6,10], which represents also an economic
advantage considering an estimated cost of $4 USD per manually
counting sample, thus the return on investment can be easily
covered in a short time for laboratories processing large-scale
analyses, in addition to the beneﬁts of reducing variability
associated to human-error.
Nowadays there are several automated cell-count systems
available such as Cedex HiRes System (Roche), LunaTM (Logos
Biosystem) and CellometerTM Auto T4Cell Viability Counter
(Peqlab), TC10TM and TC20TM (Bio-Rad), Countess1Automated
Cell Counter (Invitrogen) and Vi-CELL1 XR Cell Viability Analyzer
(Beckman Coulter). In general, automated cell count instruments
consist of a digital camera to obtain images and the analyses are
performed through specialized software that requires a minimal
user involvement [10]. Although automated instruments facilitate
the process of analyzing samples, they are constrained by the
availability of a few compatible staining options, and may be
imprecise in differentiating some types of cells due to technical
limitations in their hardware and software [12,8].
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The semi-automated Countess1 from Invitrogen (Carlsbad, CA)
and the fully automated Vi-CELL1 XR from Beckman Coulter
(Fullerton, CA) (Table 1) are two instruments currently employed
in viable cell-counts at many laboratories worldwide, that along
with the hemocytometer, perform viable cell-counts based on the
trypan blue exclusion technique. This technique is capable of
revealing damaged cells, since the dye penetrates through their
damaged membrane resulting in blue stained cells that are
regarded as non-viable, whereas non-stained cells are assumed
to be intact and are considered as viable [9,11,1].
In order to determine the suitability of each of these viable cell
count methods, they were evaluated in their performance towards
the compliance of measurable attributes such as: speciﬁcity,
accuracy, precision, linearity and range, through a validation. For
this purpose we standardized the sample preparation, and
adjusted the settings in order to obtain viable cell-counts using
CHO-K1 and U937 cells that are employed for the biosynthesis and
bioassays of recombinant proteins respectively. The suitability of
these methodologies was evaluated through a validation according
to the ICH Q2R1 guideline [2,3].
2. Materials and methods
2.1. Materials
CHO-K1 cells (CRL-CCL 61) and U937 (CRL-1593.2) were
acquired from ATCC1 (Manassas, VA). RPMI 1640 medium, PBS
1X pH 7.4 and 0.4% trypan blue solution were purchased from
Gibco1-Life technologiesTM (New York, GI). ViaCheckTM Control
beads (concentration: 1, 4 and 8  106 beads/mL, and viability: 0,
50, 75, 90, and 100%) were acquired from Bangs Laboratories, Inc.
(Fishers, IN). Countess1 Automated Cell Counter and Countess1
cell counting chamber slides were acquired from Invitrogen
(Carlsbad, CA). Vi-CELL1 XR Cell Viability Analyzer, Vi-CELL1 XR
Quad Pak Reagent Kit and Coulter CC Size standard Mix kit (2, 5, 10,
20 and 43 mm latex Beads) were purchased from Beckman Coulter
(Fullerton, CA). Trypan blue powder was obtained from Sigma–
Aldrich (St. Louis, MO). Fetal bovine serum was acquired from PAA
Laboratories (Linz, AT). DM222 A11- Liquid media were purchased
from Irvine Scientiﬁc (Santa Ana, CA).
2.2. Sample preparation
We employed concentration standards of 1, 4 and 8  106
beads/mL, (concentrations stated in the manufacturer’s certiﬁcate
of analysis “COA”) that did not require further preparation;
additionally in order to have ﬁve points for constructing a
concentration curve, we prepared two extra concentration stand-
ards of 2  106 and 6  106 beads/mL, by mixing 500 mL of the
4 106 beads/mL standard with 500 mL of 1X PBS, and 750 mL of
the 8  106 beads/mL standard with 250 mL of 1X PBS, respectively.
For viability, we used standards of 0, 50, 75, 90 and 100%
viability (viabilities stated in the manufacturer’s COA) that did not
require further preparation, in addition, to construct a ﬁve point
viability curve we prepared a 25% viability standard was by mixing
500 mL of the 50% viability standard with 500 mL of the 0% viability
standard.
To analyze cell concentration, cells were diluted in their
corresponding media at the same concentrations of standards (1, 2,
4, 6 and 8  106 cells/mL), while to evaluate cell viability, non-
viable cells were obtained by inducing thermal stress at 70 C
throughout 180 min, unviability was conﬁrmed through the
staining pattern and morphology of stressed cells in the
hemocytometer; thereafter, stressed cells were mixed with viable
cells at different proportions in order to obtain comparable results
to viability standards.
2.3. Manual counts
50 mL of sample was mixed with 50 mL of 0.4% trypan blue by
gently pipetting, and then 20 mL of the mix were loaded into each
chamber of the hemocytometer. Counts were performed by
triplicate by one analyst under a 40 objective according to the
standard methodology [6].
2.4. Semi-automated cell count
In order to standardize the Countess method, we tested
different concentrations of trypan blue (from 0.4% to 1.0%) to
determine the best staining conditions to perform the readings,
being 0.8% the concentration that worked better for our analyses
(Fig. 1). The focus of the instrument was calibrated using particle
size standards of 5, 10 and 20 mm. A cell count was performed by
mixing 20 mL of sample with 20 mL of 0.8% trypan blue solution,
afterwards the mixture was loaded into the chamber slide. A cell-
count protocol was customized accounting for sensitivity, circu-
larity, maximum and minimum size, and was applied for readings
of both standards and samples (Table 2).
Table 1
Comparison of technical parameters between the viable cell counting methods evaluated in this study.
Cell counting
system
Auto-
sample
Staining options Size range
(mm)
Sample
volume
(mL)
Analysis time
(min)
Concentration
range (cells/
mL)
Viability
range
Imaging technology
Hemocytometera,
b,c
No Erythrosin B, Nigrosin, Safranin,
Methylene blue and Trypan blue
Undeﬁned 50 Concentration
sample-
dependent
2.5 105–
8.0  106
0–100 Microscope objective 40
Countessd No Trypan blue 8–60 20 <1 1 104–1 107 0–100 Camera 2.3
objective and 3.1 Mega pixel
Vi-CELL1 XRe,f Yes Trypan blue 2–70 500 <2.5 5 104–1 107 0–100 Auto-focus routine ﬁrewire
camera 1394 1040CCD array
a Bastidas O. Cell counting with Neubauer chamber. Technical note. Celeromics: 1–6
b Hsiung F, McCollum T, Hefner E and Rubio T. Comparison of count reproducibility, accuracy, and time to results between a hemocytometer and TC20TM Automated cell
counter. Technical note: Bio-Rad Laboratories, Inc., 2013.
c Maruhashi F, Murakami S, Baba K. Automated monitoring of cell concentration and viability using image analysis system. Cytotechnology 1994; 15: 282–289.
d The Countess1 Automated Cell Counter. Invitrogen1. Technical Note. www.invitrogen.com.
e Vi-CELL1Series Cell Viability Analyzers. Product Brochure. Beckman Coulter. 2004. www.beckmancoulter.com/Literature/BioResearch/BR-9713B.pdf.
f Bioprocessing Feature of the Beckman Coulter1 Vi-CELLTM. Technical Note. Beckman Coulter1. B2004-6330. 2004.
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2.5. Automated cell counts
For the analysis in the Vi-CELL1 XR, 1 mL of diluted samples
were loaded into the carrousel (no manual mixture of the samples
with trypan blue is required since it is carried out automatically by
the instrument). The parameter settings were established accord-
ing to the recommended by the manufacturer of the standards and
were applied for standards and samples (Table 2).
2.6. Validation protocol
The validation protocol was designed to evaluate linearity,
range, speciﬁcity, accuracy, and repeatability-precision of each
method.
2.6.1. Linearity and range
Linearity and range of the three methods were evaluated using
concentration standards, viability standards and cells prepared at
the same concentrations and percentages of the standards, as
mentioned in preparation of samples. Samples were prepared and
analyzed by triplicate, and the results were collected and plotted
by linear ﬁt against the expected concentrations in the range from
1 to 8  106 units/mL using Minitab1 v.15.0 statistical software
(Minitab Inc., State College, PA). Linearity of viability was
determined by the same procedure used for the range from 0 to
100% for beads or cell lines. Intercept, slope and correlation
coefﬁcient (R2) values were reported.
2.6.2. Speciﬁcity
This parameter was evaluated on the matrix (media or buffer
employed in the preparation of samples) in order to demonstrate
speciﬁcity against cell-like particles that may interfere with the
readings in the Countess1 and Vi-CELL1 XR instruments.
Speciﬁcity was evaluated only for the automated methods since
their hardware and software are likely to misidentify cell-like
particles and consider them as cells.
2.6.3. Accuracy
Accuracy of the three methods was assessed using concentra-
tion standards (1, 2, 4, 6 and 8  106 units/mL), viability standards
(0, 25, 50, 75 and 100%) and the two cell lines prepared at the same
concentration and percentages of the control beads. Samples were
prepared by independent triplicates for each cell-count method.
The recovery percentages were related to theoretical values.
2.6.4. Precision (repeatability)
Repeatability was evaluated, as the relative standard deviation
(RSD) among runs, for all counting methods using sextuplicates of
control beads and samples prepared at a unique concentration of
1 106 units/mL. Samples were prepared on the same day by the
same analyst.
3. Results and discussion
It is well standardized that the 0.4% trypan blue concentration is
the most appropriate to provide the better visualization of
damaged cells by the human eye through a 40 microscope
objective, towards determining viable and non-viable cell counts
with a hemocytometer. Vi-CELL1 XR also employs the same trypan
blue concentration since it provides an appropriate resolution for
image acquisition by the Auto-focus camera; however, for this
comparative validation exercise Countess1 required an adjust-
ment in staining in order to obtain a better resolution of stained
cells from the background, for a posterior differentiation among
viable and non-viable cells. We observed that as the trypan blue
concentration increased from 0.4 to 1.0% the cell staining
improved, as shown by the images acquired by the instrument's
camera (Fig. 1a); however, since the instrument’s software
processes the images as 1-bit binary images, when the trypan
blue concentration was 1.0%, the background noise intensity
interfered with the capability of the instrument to properly
distinguish cells from the background (Fig. 1b); nevertheless, no
signiﬁcant background noise interference was observed between
0.4 and 0.8%, being the latter the one we chose since it was the
concentration that provided a better differentiation of stained cells
Fig. 1. Comparison of images acquired by the Countess1 camera at different trypan
blue concentrations: (a) Presents the images as were acquired by the instrument
camera, while (b) Represents images as they were analyzed by the software. At the
concentration of 1.0% the background noise interfered with the capability of the
instrument to perform more accurate and precise counts.
Table 2
Customized parameters for Vi-CELL1 XR and Countess1.
Instrument Control
protocola
Viability
protocola
Vi-CELL1XR
(Cell viability
Analyzer v2.04)
Parameter
Minimum diameter
(mm)
2 5
Maximum diameter
(mm)
50 50
Images # 50 50
Aspirate cycles 2 2
Trypan blue mixing
cycles
3 3
Cell brightness (%) 70 85
Cell sharpness 75 100
Viable cell spot
brightness (%)
55 60
Viable cell spot area
(%)
1 3
Minimum circularity 0.9 0.9
Decluster degree Low Low
Instrument Protocol Settings
Countess1 (Software v2.05) Sensitivity 6
Minimum size (mm) 8
Maximum size (mm) 15
Cicularity (%) 100
a Parameters settings recommended by the manufacturer of the standards.
D. Cadena-Herrera et al. / Biotechnology Reports 7 (2015) 9–16 11
Fig. 2. Concentration linearity obtained for: (A) CHO-K1 cells by hemocytometer, (B) U937 cells by Countess1, and (C) CHO-K1 cells by Vi-CELL1 XR; all compared versus
concentration beads.
12 D. Cadena-Herrera et al. / Biotechnology Reports 7 (2015) 9–16
in binary images and allowed the software to perform the analysis
with more precision and accuracy than the other trypan blue
concentrations.
3.1. Linearity and range
3.1.1. Hemocytometer
Curves of cell concentration and cell viability obtained for both
cell lines and beads using the hemocytometer, ﬁtted using a linear
model within the studied ranges (concentration: 1 106 to 8  106
units/mL and viability: 0–100% for the three methods) (Fig. 3). R2
values were 0.99 in all cases, and the slopes varied from 0.938 for
the concentration curves of beads to 1.002 for the viability of CHO-
K1 cells (Table 3).
3.1.2. Countess1
Cell concentration and cell viability curves obtained from the
Countess1 ﬁtted with a linear model within the studied ranges
(Fig. 2). R2 values for the concentration curves were 0.99 in all the
cases, while for viabilities the R2 values varied between 0.98 and
0.99 (Table 3). However, slopes showed differences among the
bead counts (m = 1.038) and cell counts for CHO-K1 cells (m = 0.80)
this difference might be attributable to the difference in size and
morphology of CHO-K1 cells with respect to the beads (cells are
larger than the beads) that inﬂuenced the capability of the
instrument to disregard cells during countings. It was observed
that as the cell titration increased, the difference with respect to
the expected value also increased. This variability suggests that the
capabilities in the hardware and software of the instrument that
are inﬂuenced by the adjustment of circularity, size range and
sensitivity settings, and the accurate range recommended by the
manufacturer (1 104 to 4 106 units/mL) require to be custom-
ized for each cell line.
3.1.3. Vi-CELL1 XR
R2 values obtained from cell counts and viability measurements
within the studied ranges using Vi-CELL1 XR were >0.99 in all
cases (Fig. 2). Linearity evaluated through this method was similar
to the obtained from the hemocytometer as denoted by their R2
values; furthermore results between cells and beads were similar
(Table 3). Despite that the Vi-CELL1 XR uses an automated imaging
system controlled by software, this instrument provided more
consistent results than Countess1; this consistency might be
associated with an improved imaging technology and the
ﬂexibility in the adjustment of input parameters such as
brightness, circularity, size, cell spot area, dilution factor, and
the capability to differentiate cells within clusters allowing a more
extensive major control for analyzing samples.
3.2. Speciﬁcity
Media and buffer were analyzed by the Countess1 for matrix
effects which displayed an alert stating that the measurements
were below the lower limit that the instrument is capable of
measuring (1 104 units/mL) as expected for this parameter since
the samples lacked cells. On the other hand, speciﬁcity measure-
ments conducted with the Vi-CELL1 XR provided counting values
of 0.00 units/mL and 0.0% viability, indicating no interference of
matrix effect with the readings and that this method is speciﬁc as
well. In summary, Countess1 and Vi-CELL1 XR were demonstrated
to be speciﬁc for detecting both cells and beads without
interference of media or buffer matrix.
3.3. Accuracy
According to the results from the accuracy tests, a global
averaged recovery of 99.4% (calculated from the collective recovery
values for the two cell lines and beads) was obtained using the
hemocytometer (Table 4). For Vi-CELL1 XR and Countess1 the
global averaged recovery values were 104.7% and 99.25%,
respectively. Viability readings obtained by the three methods
were comparable for concentration percentages (Table 4). Both
viability and concentration data ﬁtted within the recovery range of
90–110%. The Countess1 presents major variability at higher cell
concentrations. This result might be associated with a major
degree of cell clusterization at higher cell concentrations, and the
instrument is unable to recognize them as independent units and
excludes them from the analyses. It is remarkable that as the cell
concentration increased the error decreased, because the proba-
bility of including a representative number of cells in the sample
under the visual ﬁeld is higher at a major cell density up to the
saturation, which determines the linear range of analysis.
Table 3
Concentration and viability linearity results obtained by the three cell counting methods for each cell line and standards.
Attribute Method Cell line/standard R2 y
Concentration Hemocytometer U937 cells 0.9999 0.996x + 42134
CHO-K1 cells 0.9999 1.000x  52256
Concentration beads 0.9959 0.938x + 16037
Countess1 U937 cells 0.9993 0.983x + 13494
CHO-K1 cells 0.994 0.802x  426.83
Concentration beads 0.9927 1.038x + 27317
Vi-Cell1XR U937 cells 0.9999 0.982x + 19555
CHO-K1 cells 0.9991 0.989x + 53415
Concentration beads 0.9968 0.905x + 39531
Viability Hemocytometer U937 cells 0.9989 0.982x + 0.2117
CHO-K1 cells 0.998 1.002x + 0.9229
Viability standards 0.9995 0.996x + 0.7791
Countess1 U937 cells 0.9804 0.878x + 5.5657
CHO-K1 cells 0.9928 0.940x  0.2851
Viability standards 0.9873 0.991x + 1.7119
Vi-Cell1XR U937 cells 0.9984 0.980x + 1.5634
CHO-K1 cells 0.9995 1.007x + 0.1424
Viability standards 0.9991 1.006x + 1.1386
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Fig. 3. Viability linearity obtained for: (A) CHO-K1 cells by hemocytometer, (B) U937 cells by Countess1, and (C) CHO-K1 cells by Vi-CELL1 XR; all compared versus viability
standards.
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3.3.1. Precision (repeatability)
The RSD values for the system precision tests using a
hemocytometer were 8.06% for U937 cells, 0.75% for concentration
beads and 2.81% for CHO-K1 cells (Table 5). Vi-CELL1 XR always
showed RSD values  5.28%. Countess1 presented more variability,
since its lower RSD value was 11.04% for CHO-K1, whereas its
higher value was up to 14.30% for beads (Table 5).
4. Conclusions
According to the results obtained from this work, we observed
that the three methods are suitable to perform viable cell counts. In
general, the hemocytometer and Vi-CELL1 XR showed similar
results in all the evaluated characteristics. Results obtained by the
Countess1 were more variable than that obtained by the other
methods; nevertheless, this variability can be acceptable for
considering the Countess1 as an alternative to the hemocytometer
in processes that involve the analyses of a lot of samples, as long as
this variability will not affect the process under study.
Despite the manual method continuing to be the more employed
due to the quality of its results and low cost, it requires a certain
degree of expertise of the analyst and it is time consuming;therefore,
it is difﬁcult to be implemented for large-scale analyses, on the other
hand Vi-CELL1 XR and Countess1 provide the opportunity of
analyzing a huge number of samples in a short time with reliable
results, after the adjustment of the instruments for cell type and cell
culture growth parameters.
Other advantages of using automated systems such as Vi-CELL1
XR and Countess1 is that their hardware and software comply with
the international regulations for working under a good
manufacturing practices environment, and the data obtained from
the analyses is stored under a security-chronological record (audit
trail). Likewise, the manufacturers provide technical support,
documentation and recommendations to the personnel at each
laboratory to perform installation and operational qualiﬁcation
(IQ/OQ) procedures, which facilitates the process of validation of
the instruments.
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Table 4
Recovery values obtained by each cell counting method.
Cell lines/
standards
Concentration
(units/mL)
Viability
(%)
Hemocytometer Countess1 Vi-CELL1 XR
Count recovery
(%)
Viability recovery
(%)
Count recovery
(%)
Viability recovery
(%)
Count recovery
(%)
Viability recovery
(%)
U937 1 106 25 102.0  2.5 100.9  18.4 117.0  45.6 106.7  15.2 119.3  10.3 105.3  16.5
2  106 50 103.3  5.2 95.3  7.6 106.7  19.0 92.7  17.4 106.8  1.9 106.1  7.2
4 106 75 99.7  2.5 101.0  6.5 98.8  13.5 84.9  49.6 102.8  1.9 101.2  4.0
6  106 90 100.8  1.3 97.0  4.2 100.0  21.9 98.5  3.2 102.1  1.3 99.0  2.1
8  106 100 100.5  1.9 98.7  1.4 100.8  16.6 97.3  7.6 100.3  4.1 98.3  0.4
CHO-K1 1 106 25 99.0  7.4 99.1  45.0 92.5  10.8 100.7  15.9 99.3  5.9 97.1  23.9
2  106 50 95.3  8.7 91.3  12.5 78.3  28.0 84.7  12.5 103.2  8.2 101.7  14.4
4 106 75 98.4  5.2 99.4  4.5 79.2  7.8 96.0  15.2 102.4  3.2 100.3  10.1
6  106 90 98.8  1.9 100.7  6.8 75.8  2.1 90.0  2.8 97.6  0.3 101.8  6.9
8  106 100 99.6  2.5 99.4  0.7 82.7  5.5 97.0  6.6 100.1  6.0 99.4  0.7
Beads 1 106 25 98.7  1.4 102.4  3.6 113.3  28.7 100.0  24.3 117.7  16.5 88.8  18.9
2  106 50 101.7  3.1 104.5  15.2 123.3  7.2 138.3  13.8 110.7  6.1 97.0  2.2
4 106 75 100.0  1.1 99.7  5.0 118.3  12.9 94.7  18.9 103.2  5.9 98.8  1.5
6  106 90 100.4  0.7 100.6  0.8 102.8  16.7 102.4  5.3 99.8  4.2 100.1  1.3
8  106 100 93.2  1.8 99.9  0.3 108.3  17.9 99.8  1.0 93.2  1.8 99.7  0.8
Table 5
Repeatibility obtained by the three cell counting methods evaluated by RSD.
Viable cell counting method Cell line/standard Mean(1 106 units/mL) Standard deviation (1 105) %RSD
Hemocytometer U937 1.05 0.85 8.06
CHO-K1 0.97 0.27 2.81
Beads 0.99 0.07 0.75
Vi-CELL1 XR U937 1.14 0.26 2.27
CHO-K1 0.99 0.55 5.28
Beads 1.09 0.40 3.68
Countess1 U937 1.04 1.30 12.50
CHO-K1 0.89 0.99 11.04
Beads 1.10 0.16 14.30
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